Maple Rock Capital Partners Inc. TEVA Holdings History
Maple Rock Capital Partners Inc.'s Teva Pharmaceutical Industries Ltd Holding Summary
As of 2025-03-31, Maple Rock Capital Partners Inc. held - shares of Teva Pharmaceutical Industries Ltd(TEVA), totaling N/A. This investment constitutes 0% of their stock portfolio, and Maple Rock Capital Partners Inc. now holds 0% of the outstanding Teva Pharmaceutical Industries Ltd(TEVA) stock.
The initial trade took place in 2023Q4. And since then Maple Rock Capital Partners Inc. has made 4 purchases of TEVA, at an average price of $10.89, for a total of 4.56 Mil shares. In addition, there have been 2 sales at an average price of $17.89 for 4.56 Mil shares. Based on historical transaction data and TEVA's current price of $16.40, Maple Rock Capital Partners Inc.'s estimated gain on his TEVA holdings is $31.89 Mil, reflecting a 64.22% gain to date.
Maple Rock Capital Partners Inc. TEVA ($16.40) Holding Chart
Maple Rock Capital Partners Inc. TEVA ($16.40) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
